Long-term continuous steroid therapy should be avoided since adrenal suppression can occur, particularly when occlusive dressings are applied. In addition, long term therapy with corticosteroids can cause skin lesions such as atrophy, telangiectasia and striae.
The overgrowth of nonsusceptible organisms, including fungi, occasionally occurs with the use of topical antibiotics.
If this occurs, or if irritation, sensitization, or superinfection develops, treatment with ENDIX-G should be discontinued and appropriate therapy instituted.
In cases of known sensitivity to propylene glycol, patients should consult podiatrist or physician before treatment.
ENDIX-G should not be administered during pregnancy unless the possible risks involved have been carefully considered.
Introduction of the product into the eye should be avoided.